Posted on: 14th February 2018
If you are heading to BioProcess International West in March you will probably be aware that Reed Harris, Technical Development Senior Staff Scientist, Global Technical Development (PTD), Genentech, is delivering a talk on BPOG’s Technology Roadmapping process. The creation of the first edition Biomanufacturing Technology Roadmap has quickly led to the implementation of several projects that will provide the step change required to address key future innovation challenges identified by the member organisations.
Harris will be delivering a speech on the evolution of the global technology roadmap and its development within BPOG. This will cover the first edition of the roadmap, the current key projects which are underway and the scope for the second edition.
BPI recognises the value of the outputs from the BPOG Technology Roadmapping Phorum, that facilitated the publication of the first edition Roadmap. By bringing together the leading technological strategists from both manufacturers and supplier companies, the Phorum rapidly developed a series of direct benefits to the members as well as the wider community.
When BPOG published the first edition Roadmap document in 2017 it was very well received by the sector and is now being implemented across the biomanufacturing industry. As innovation continues to rapidly progress, BPOG will begin to develop the scope for a second edition at a kick-off meeting in May 2018. This event will allow the members’ steering committee, a group of 40+ industry leaders, to work on an extended vision for the future of biomanufacturing beyond monoclonal antibodies which was the main focus of the first edition.
You can watch the testimonial videos on the website to hear directly from our members how exciting and innovative this work is for their business and the presentation at BPI wil give a great overview of the Roadmap. You can download the Roadmap from our website here.
In addition to the presentation on the development of the Technology Roadmap, Amie Lundquist, Shire, will be presenting on behalf of the Monoclonality point share within Development Group. The presentation, titled ‘Industry Perspectives and Case Studies towards Demonstration of Monoclonality for Biologics Manufacture development’, will present an industry perspective providing alternative approaches to composition of a regulatory submission to support a monoclonality claim. These approaches represent the views of a consortium of companies within the BioPhorum Development Group and include case studies utilising imaging technology including scientifically sound approaches and efforts in demonstrating monoclonality
BioProcess International West (BPI West) is the leading phase-based bioprocessing event for advancing promising biologics towards commercial success. Join 850+ global scientists and key decision makers at our upcoming meeting, held March 19-22, 2018 in San Francisco, CA. BPOG members will be delivering numerous podium presentations covering the technology road mapping process, monoclonality for biologics manufacture, and development of single-use standards.
BPOG members can save an extra 10% off current rates when you register online at https://goo.gl/nPGamU with VIP code BPOG10 by March 2, 2018. For questions, please contact Howie Choi at email@example.com.